|
It's been two years since the U.S. Food and Drug Administration approved Gardasil, the first vaccine to help prevent cervical cancer and other conditions caused by particular types of genital human papillomavirus (HPV). HPV is the most common cause of new sexually transmitted diseases. According to the first national estimate of use, 25 percent of teenage girls received at least one dose of the Gardasil vaccine in 2007, with 20 million doses distributed in U.S. The HPV vaccine has made news frequently, as parents weigh the benefits, the high cost, claims of adverse reactions and unease about vaccinating their kids from a sexually transmitted disease. We talk to Lydia Shrier, MD, MPH, about these concerns, and the potential of Gardasil.
What is HPV and how prevalent is it in the U.S?
It is a group of more than 100 different types of viruses, more than 30 of which are sexually transmitted. Low-risk types of HPV can lead to benign, but bothersome, genital warts or abnormal changes in the cervix, but generally don't progress to serious disease. However, high-risk types can lead to cervical cancer and, rarely, cancers of the vulva, vagina, anus or penis. There is no cure for HPV and a person can have more than one type. The vast majority of sexually active people, by the end of their life, will have been exposed to the virus. Most people who have acquired HPV infection don't know that they have it because they don't have any symptoms. Pap smear screening is where we detect abnormalities that lead to cervical cancer.
Gardasil, a vaccine against HPV, was released in 2006. How effective is it at protecting women from HPV?
Gardasil is very effective in preventing acquisition of infection from four types of HPV--the two types that cause more than 70 percent of cervical cancer, and the two types that cause 90 percent of the cases of genital warts.
The CDC recently released statistics showing that 25 percent of teenage girls have received Gardasil to protect against cervical cancer. Is this a good start?
Currently I'm recommending Gardasil for all of my teenage patients. I would like it to be 100 percent. Every year in the United States, there are over 11,000 new cases of cervical cancer and more than 3,800 deaths from cervical cancer. With the vaccine, we have the opportunity to offer protection to young women before they've been exposed to HPV.
|